Why a randomized melanoma screening trial is not a good idea

J A Halvorsen; M Løberg; P Gjersvik; I Roscher; M B Veierød; T E Robsahm; L T N Nilsen; M Kalager; M Bretthauer

doi:10.1111/bjd.16784

Why a randomized melanoma screening trial is not a good idea

Br J Dermatol. 2018 Aug;179(2):532-533. doi: 10.1111/bjd.16784. Epub 2018 Jun 12.

Authors

J A Halvorsen^{1

2}, M Løberg^{2

3

4}, P Gjersvik^{1

2}, I Roscher¹, M B Veierød^{2

5}, T E Robsahm⁶, L T N Nilsen⁷, M Kalager^{2

3}, M Bretthauer^{2

3

4}

Affiliations

¹ Department of Dermatology, Oslo University Hospital, Oslo, Norway.
² Faculty of Medicine, University of Oslo, Oslo, Norway.
³ Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.
⁴ Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
⁵ Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Oslo, Norway.
⁶ Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway.
⁷ Norwegian Radiation Protection Authority, Østerås, Norway.

PMID: 29893490
DOI: 10.1111/bjd.16784

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Biopsy
Early Detection of Cancer / methods*
Germany / epidemiology
Humans
Mass Screening / methods*
Melanoma / diagnosis*
Melanoma / mortality
Melanoma / pathology
Melanoma / prevention & control
Middle Aged
Norway / epidemiology
Observational Studies as Topic
Randomized Controlled Trials as Topic*
Research Design
Sample Size
Skin / pathology
Skin Neoplasms / diagnosis*
Skin Neoplasms / mortality
Skin Neoplasms / pathology
Skin Neoplasms / prevention & control
Young Adult